METAIN Introduces Real Estate Cross-Border Co-Investment Solution With Yield of Interest of 15-25% to Global Investors – QNT Press Release4 years ago
I-Mab Announces Positive Phase 2 Data of Lemzoparlimab in Combination with Azacitidine (AZA) in Patients with Higher Risk Myelodysplastic Syndrome at ESMO 2022 – QNT Press Release4 years ago
